INCY vs STE
Incyte vs Steris — AI-powered side-by-side comparison
| Metric | INCY | STE |
|---|
| AI Score |
71
|
54
|
| Price |
$127.83
|
$237.96
|
| P/E Ratio |
15.72×
|
29.02×
|
| ROE |
24.9%
|
10.9%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
92.6%
|
44.4%
|
| Debt / Equity |
0.01×
|
0.28×
|
| Dividend Yield |
0.0%
|
1.1%
|
| RSI (14) |
71.2
|
62.9
|
| Beta |
0.769
|
0.914
|
| Expected Upside |
—
|
+6.2%
|
AI Committee View
Current Innellis committee reasoning for INCY versus STE.
INCY leads by 17 points.
INCY scores 71/100 (Buy) versus STE at 54/100 (Watch).
INCY Committee View
100% agreement
6 analysts
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull Case
- ROE of 29.6% shows genuine earnings power backing the valuation — Value
- Revenue growing 26.9% YoY -- genuine top-line momentum — Growth
- EPS growing 80.3% YoY — Growth
Bear Case
- RSI at 71 is in overbought territory — Technical
- Weekly RSI at 81 -- overbought on the larger timeframe too — Technical
STE Committee View
50% agreement
4 analysts
The committee is genuinely divided. News Analyst sees a compelling case — news sentiment is positive (+0.33 across 9 articles, 14d). Growth Analyst remains cautious — growth rate is decelerating quarter over quarter -- the trend line matters more than the level. This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- News sentiment is positive (+0.33 across 9 articles, 14d) — News
Bear Case
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
- MACD histogram negative -- bearish momentum — Technical